메뉴 건너뛰기





Volumn 95, Issue 2, 2008, Pages 185-190

Methodological approaches of clinical studies with targeted therapies;Particularités méthodologiques des études cliniques appliquées à l'évaluation des thérapeutiques ciblées

Author keywords

Biomarkers; Methodology; Phase II; Targeted therapie

Indexed keywords

BIOLOGICAL MARKER; CYTOTOXIC AGENT; ERLOTINIB; IMATINIB; IMMUNOSTIMULATING AGENT; METALLOPROTEINASE INHIBITOR; PLACEBO;

EID: 40349105988     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0575     Document Type: Review
Times cited : (8)

References (54)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.